These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24832003)

  • 1. Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?
    Boye KS; Matza LS; Feeny DH; Johnston JA; Bowman L; Jordan JB
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):437-50. PubMed ID: 24832003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should "standard gamble" and "'time trade off" utility measurement be used more in mental health research?
    Flood C
    J Ment Health Policy Econ; 2010 Jun; 13(2):65-72. PubMed ID: 20919593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deriving time discounting correction factors for TTO tariffs.
    Attema AE; Brouwer WB
    Health Econ; 2014 Apr; 23(4):410-25. PubMed ID: 23564665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in Valuing Temporary Health States for Economic Evaluation: A Review of Empirical Applications of the Chained Time Trade-Off Method.
    Stoniute J; Mott DJ; Shen J
    Value Health; 2018 May; 21(5):605-611. PubMed ID: 29753359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO.
    Heintz E; Wiréhn AB; Peebo BB; Rosenqvist U; Levin LÅ
    Value Health; 2012 May; 15(3):475-84. PubMed ID: 22583458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are people consistent when trading time for health?
    Oliver A; Wolff J
    Econ Hum Biol; 2014 Dec; 15():41-6. PubMed ID: 24953641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions.
    Matza LS; Boye KS; Feeny DH; Johnston JA; Bowman L; Jordan JB
    Health Qual Life Outcomes; 2014 Apr; 12():48. PubMed ID: 24716709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of utility.
    Thavorncharoensap M
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S43-9. PubMed ID: 24964698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation.
    Matza LS; Boye KS; Feeny DH; Bowman L; Johnston JA; Stewart KD; McDaniel K; Jordan J
    Eur J Health Econ; 2016 Nov; 17(8):979-990. PubMed ID: 26611792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain quality of life as measured by utilities.
    Wetherington S; Delong L; Kini S; Veledar E; Schaufele MK; McKenzie-Brown AM; Chen SC
    Pain Med; 2014 May; 15(5):865-70. PubMed ID: 24716656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of medical, demographic and psychosocial factors to direct and indirect health utility instruments in rheumatoid arthritis.
    Witney AG; Treharne GJ; Tavakoli M; Lyons AC; Vincent K; Scott DL; Kitas GD
    Rheumatology (Oxford); 2006 Aug; 45(8):975-81. PubMed ID: 16461437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A note on the nature of utility in time and health and implications for cost utility analysis.
    Buckingham KJ; Devlin NJ
    Soc Sci Med; 2009 Jan; 68(2):362-7. PubMed ID: 19019518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a Danish TTO value set for EQ-5D health states.
    Wittrup-Jensen KU; Lauridsen J; Gudex C; Pedersen KM
    Scand J Public Health; 2009 Jul; 37(5):459-66. PubMed ID: 19411320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inconsistencies in TTO and VAS values for EQ-5D health states.
    Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
    Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are QALYs based on time trade-off comparable?--A systematic review of TTO methodologies.
    Arnesen T; Trommald M
    Health Econ; 2005 Jan; 14(1):39-53. PubMed ID: 15386674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility, comparability, and reliability of the standard gamble compared with the rating scale and time trade-off techniques in Korean population.
    Kim SH; Lee SI; Jo MW
    Qual Life Res; 2017 Dec; 26(12):3387-3397. PubMed ID: 28801862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
    Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
    Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What value health?: A review of health state values used in early technology assessments for NICE.
    Stein K; Fry A; Round A; Milne R; Brazier J
    Appl Health Econ Health Policy; 2005; 4(4):219-28. PubMed ID: 16466273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.